PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) COGS-to-Revenue : 0.60 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk COGS-to-Revenue?

PT Kalbe Farma Tbk's Cost of Goods Sold for the three months ended in Mar. 2024 was $327 Mil. Its Revenue for the three months ended in Mar. 2024 was $542 Mil.

PT Kalbe Farma Tbk's COGS to Revenue for the three months ended in Mar. 2024 was 0.60.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PT Kalbe Farma Tbk's Gross Margin % for the three months ended in Mar. 2024 was 39.71%.

PT Kalbe Farma Tbk COGS-to-Revenue Historical Data

The historical data trend for PT Kalbe Farma Tbk's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk COGS-to-Revenue Chart

PT Kalbe Farma Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.55

0.56

0.57

0.60

0.61

PT Kalbe Farma Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.59	0.60	0.63	0.63	0.60

PT Kalbe Farma Tbk COGS-to-Revenue Calculation

PT Kalbe Farma Tbk's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1208.218	/	1975.164
	=	0.61

PT Kalbe Farma Tbk's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	327.046	/	542.49
	=	0.60

PT Kalbe Farma Tbk (OTCPK:PTKFY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PT Kalbe Farma Tbk's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	327.046 / 542.49
	=	39.71 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

PT Kalbe Farma Tbk COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

PTKFF:USA KLBF:Indonesia

Address

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510

Website

https://www.kalbe.co.id

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines